Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-γ activations in endothelial cells

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 405-411

  Nizamutdinova, Irina Tsoy ^a   Kim, Young Min ^a   Kim, Hye Jung ^a   Seo, Han Geuk ^a   Lee, Jae Heun ^a   Chang, Ki Churl ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

AMP activated protein kinase; Carbon monoxide; Endothelial cells; Hyperglycemia; PPAR gamma

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 2; CHEMICAL COMPOUND; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERCELLULAR ADHESION MOLECULE 1; LUCIFERASE; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ASSAY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOTHESIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANILIDES; ANTI-INFLAMMATORY AGENTS; BENZOPHENONES; CARBON MONOXIDE; CELL ADHESION; CELLS, CULTURED; CHROMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ENZYME ACTIVATORS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; ORGANOMETALLIC COMPOUNDS; PPAR GAMMA; PROTEIN KINASE INHIBITORS; PYRAZOLES; PYRIMIDINES; RIBONUCLEOTIDES; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TIME FACTORS; TRANSFECTION; TYROSINE;

EID: 70549084059     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.05.008     Document Type: Article

References (23)

1. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
2. Chuang K.P., Huang Y.F., Hsu Y.L., Liu H.S., Chen H.C., and Shieh C.C. Ligation of lymphocyte function-associated antigen-1 on monocytes decreases very late antigen-4-mediated adhesion through a reactive oxygen species-dependent pathway. Blood 104 (2004) 4046-4053
3. Sumagin R., and Sarelius I.H. A role for ICAM-1 in maintenance of leukocyte-endothelial cell rolling interactions in inflamed arterioles. Am J Physiol Heart Circ Physiol 293 (2007) 2786-2798
4. Sumagin R., Lomakina E., and Sarelius I.H. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am J Physiol Heart Circ Physiol 295 (2008) 969-1969
5. Lopes-Virella M.F., and Virella G. Immune mechanism of atherosclerosis in diabetes mellitus. Diabetes 41 (1992) 86-91
6. Quagliaro L., Piconi L., Assaloni R., et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183 (2005) 259-267
7. Witte D.R., Broekmans W.M.R., Kardinaal A.F.M., et al. Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis 170 (2003) 147-153
8. Szekanecz Z., Shah M.R., Pearce W.H., and Koch A.E. Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1 production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol 98 (1994) 337-343
9. Sattar N., Murray H.M., Welsh P., et al. Prospective study of pravastatin in elderly at risk trial study group. Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes that vascular risk? Outcome of a prospective study in the elderly. Diabetologia 52 (2009) 235-239
10. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., and Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular acivities. Circ Res 90 (2002) e17-e24
11. Nizamutdinova I.T., Oh H.M., Min Y.N., et al. Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. Int Immunopharmacol 3 (2007) 343-350
12. Kim H.J., Woo I.S., Kang E.S., et al. Phorbol ester potentiates the growth inhibitory effect of troglitazone via upregulation of PPARgamma in A549 cells. Biochem Biophys Res Commun 349 (2006) 660-667
13. Nizamutdinova I.T., Lee G.W., Lee J.S., et al. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 29 (2008) 1885-1892
14. Ryter S.W., Alam J., and Choi A.M. Heme oxygenase/carbon monoxide: from basic science to therapeutic application. Physiol Rev 86 (2006) 583-650
15. Bilban M., Bach F.H., Otterbein S.L., et al. Carbon monoxide orchestrates a protective response through PPARγ. Immunity 24 (2006) 601-610
16. O'shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/STAT pathway. Cell 109 (2002) S121-S131
17. Chin B.Y., Jiang G., Wegiel B., et al. Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci USA. 104 (2007) 5109-5114
18. Blaschke F., Carglayan E., and Hsueh W.A. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am 35 (2006) 561-674
19. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cells?. Annu Rev Biochem 67 (1998) 821-855
20. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest 116 (2006) 1776-1783
21. Ouedraogo R., Wu X., Xu S.Q., et al. Adiponectin suppression of high glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathways. Diabetes 55 (2006) 1840-1846
22. Kukidome D., Nishikawa T., Sonoda K., et al. Activation of AMP-activated protein kinase reduces high glucose-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 55 (2006) 120-127
23. Ruderman N., and Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3 (2004) 340-351